JOHNSON & JOHNSON’S COVID-19 VACCINE RECOMMENDED BY US FDA

Highlights
• 22 members of the committee were convened by the Food and Drug Administration (FDA). It included leading scientists as well as consumer and industry representatives
• Recently the White House officials had warned that initial supplies of J&J vaccine would be limited
• President Joe Biden said “We’ve all seen the news about Johnson and Johnson vaccine today – third, safe effective vaccine.”

Johnson & Johnson’s single-dose COVID-19 vaccine has recommended by a US panel of independent experts for emergency approval.
22 members of the committee were convened by the Food and Drug Administration (FDA). It included leading scientists as well as consumer and industry representatives.
Drugmaker Johnson & Johnson had recently said it will be able to provide 20 million doses of its single-shot coronavirus vaccine by the end of March. This statement from the pharma company came on the assumption that it will get approval from the Food and Drugs Administration (FDA).
Johnson and Johnson had disclosed this number in written testimony ahead of a Congressional hearing on Tuesday looking at the vaccine supply of the United States. Recently the White House officials had warned that initial supplies of J&J vaccine would be limited.
Johnson & Johnson once again stated that it will be having the capacity to provide 100 million coronavirus vaccine doses to the United States by June end. It also said that the supply of vaccines will help government officials achieve their goal of having enough injections to vaccinate most number of adult US citizens at the end of this year.
President Joe Biden said “We’ve all seen the news about Johnson and Johnson vaccine today – third, safe effective vaccine.”
He further said that “We’re going to use every conceivable way to expand manufacturing of the vaccine and make even more rapid progress in getting vaccine shots to people’s arms.”